BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 30597548)

  • 1. CD30-positive cutaneous extranodal natural killer/T-cell lymphoma: clinicopathological features and survival outcomes.
    Lee WJ; Moon IJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
    Int J Dermatol; 2019 Jun; 58(6):688-696. PubMed ID: 30597548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
    Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities.
    Kim WY; Nam SJ; Kim S; Kim TM; Heo DS; Kim CW; Jeon YK
    Leuk Lymphoma; 2015 Jun; 56(6):1778-86. PubMed ID: 25288491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups--a retrospective study of 18 patients.
    Choi YL; Park JH; Namkung JH; Lee JH; Yang JM; Lee ES; Lee DY; Jang KT; Ko YH
    Br J Dermatol; 2009 Feb; 160(2):333-7. PubMed ID: 19014396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic analysis of cutaneous lymphoma in taiwan: a high frequency of extranodal natural killer/t-cell lymphoma, nasal type, with an extremely poor prognosis.
    Liao JB; Chuang SS; Chen HC; Tseng HH; Wang JS; Hsieh PP
    Arch Pathol Lab Med; 2010 Jul; 134(7):996-1002. PubMed ID: 20586627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
    Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
    Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of CD30+ nasal natural killer/T-cell lymphoma.
    Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
    Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type.
    Hong J; Park S; Baek HL; Jung JH; Kang IG; Sym SJ; Park J; Ahn JY; Cho EK; Kim ST; Shin DB; Lee JH
    Int J Clin Exp Pathol; 2012; 5(9):939-47. PubMed ID: 23119111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
    Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
    Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
    Li P; Jiang L; Zhang X; Liu J; Wang H
    BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extent of cutaneous lesions predicts outcome in extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract with secondary cutaneous involvement.
    Qi SN; Li YX; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Fang H; Ren H; Lu NN; Liu QF; Wu RY; Zhang XM; Liu XF; Yu ZH
    Leuk Lymphoma; 2012 May; 53(5):855-61. PubMed ID: 22035375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.
    Massone C; Chott A; Metze D; Kerl K; Citarella L; Vale E; Kerl H; Cerroni L
    Am J Surg Pathol; 2004 Jun; 28(6):719-35. PubMed ID: 15166664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and molecular features in cutaneous extranodal natural killer-/T-cell lymphoma, nasal type, with aggressive and indolent course.
    Fried I; Artl M; Cota C; Müller H; Bartolo E; Boi S; Chiarelli C; Vale E; Schmuth M; Wiesner T; Speicher MR; Cerroni L
    J Am Acad Dermatol; 2014 Apr; 70(4):716-723. PubMed ID: 24433873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extranodal nasal-type natural killer/T-cell lymphoma of the skin: a clinicopathologic study of 16 cases in China.
    Yu JB; Zuo Z; Tang Y; Zhao S; Zhang YC; Bi CF; Wang WY; Zhang WY; Wang L; Liu WP
    Hum Pathol; 2009 Jun; 40(6):807-16. PubMed ID: 19200574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.
    Kim SJ; Kim BS; Choi CW; Choi J; Kim I; Lee YH; Kim JS
    Ann Oncol; 2007 Aug; 18(8):1382-7. PubMed ID: 17693651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extranodal natural killer/T-cell lymphoma, nasal type: a Spanish multicentric retrospective survey.
    Rozas-Muñoz E; Gallardo F; Pujol RM; Pérez-Ferriols A; Servitje O; Estrach T; Bastida J; Román C; Palacio-Aller L; Gil I; Martí RM; Vidal-Sarró D; García-Muret MP
    Eur J Dermatol; 2018 Feb; 28(1):64-70. PubMed ID: 29400283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type.
    Wang KF; Chang BY; Chen XQ; Liu PP; Wuxiao ZJ; Wang ZH; Li S; Jiang WQ; Xia ZJ
    Med Oncol; 2014 Dec; 31(12):318. PubMed ID: 25377661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
    McKelvie PA; Thompson PA; Tam CS
    Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
    Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.
    Li N; Zhang L; Song HL; Zhang J; Weng HW; Zou LQ
    Tumour Biol; 2017 May; 39(5):1010428317705503. PubMed ID: 28475009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.